Advertisement
Research Article

Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis

  • Mark Hatherill mail,

    To whom correspondence should be addressed. E-mail: mark@rmh.uct.ac.za

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Tony Hawkridge,

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Andrew Whitelaw,

    Affiliations: Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa, National Health Laboratory Service, Cape Town, South Africa

    X
  • Michele Tameris,

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Hassan Mahomed,

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Sizulu Moyo,

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Willem Hanekom,

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Gregory Hussey

    Affiliations: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

    X
  • Published: December 20, 2006
  • DOI: 10.1371/journal.pone.0000021

About the Authors

Mark Hatherill, Tony Hawkridge, Michele Tameris, Hassan Mahomed, Sizulu Moyo, Willem Hanekom, Gregory Hussey
South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Mark Hatherill, Tony Hawkridge, Michele Tameris, Hassan Mahomed, Sizulu Moyo, Willem Hanekom, Gregory Hussey
School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa
Andrew Whitelaw
Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
Andrew Whitelaw
National Health Laboratory Service, Cape Town, South Africa

Corresponding Author

Email: mark@rmh.uct.ac.za

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MH TH WH GH. Performed the experiments: TH MT SM. Analyzed the data: MH AW HM. Wrote the paper: MH TH AW MT HM SM WH GH